Literature DB >> 27913232

Visual acuity and quality of life in dry eye disease: Proceedings of the OCEAN group meeting.

José Benítez-Del-Castillo1, Marc Labetoulle2, Christophe Baudouin3, Maurizio Rolando4, Yonca A Akova5, Pasquale Aragona6, Gerd Geerling7, Jesús Merayo-Lloves8, Elisabeth M Messmer9, Kostas Boboridis10.   

Abstract

Dry eye disease (DED) results in tear film instability and hyperosmolarity, inflammation of the ocular surface and, ultimately, visual disturbance that can significantly impact a patient's quality of life. The effects on visual acuity result in difficulties with driving, reading and computer use and negatively impact psychological health. These effects also extend to the workplace, with a loss of productivity and quality of work causing substantial economic losses. The effects of DED and the impact on vision experienced by patients may not be given sufficient importance by ophthalmologists. Functional visual acuity (FVA) is a measure of visual acuity after sustained eye opening without blinking for at least 10 s and mimics the sustained visual acuity of daily life. Measuring dynamic FVA allows the detection of impaired visual function in patients with DED who may display normal conventional visual acuity. There are currently several tests and methods that can be used to measure dynamic visual function: the SSC-350 FVA measurement system, assessment of best-corrected visual acuity decay using the interblink visual acuity decay test, serial measurements of ocular and corneal higher order aberrations, and measurement of dynamic vision quality using the Optical Quality Analysis System. Although the equipment for these methods may be too large or unaffordable for use in clinical practice, FVA testing is an important assessment for DED.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dry eye disease; Dynamic visual testing; Functional visual acuity; Quality of life; Tear film stability

Mesh:

Year:  2016        PMID: 27913232     DOI: 10.1016/j.jtos.2016.11.003

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  12 in total

1.  Evaluations of wavefront aberrations and corneal surface regularity in dry eye patients measured with OPD Scan III.

Authors:  Rong-Jun Liu; Bai-Kai Ma; Yu-Fei Gao; Yi-Yun Liu; Hong Qi
Journal:  Int J Ophthalmol       Date:  2022-03-18       Impact factor: 1.779

2.  Assessing the Risk Factors For Diagnosed Symptomatic Dry Eye Using a Smartphone App: Cross-sectional Study.

Authors:  Ngamjit Kasetsuwan; Olan Suwan-Apichon; Kaevalin Lekhanont; Varintorn Chuckpaiwong; Usanee Reinprayoon; Somporn Chantra; Vilavun Puangsricharern; Lalida Pariyakanok; Pinnita Prabhasawat; Nattaporn Tesavibul; Winai Chaidaroon; Napaporn Tananuvat; Chakree Hirunpat; Nauljira Prakairungthong; Wiwan Sansanayudh; Chareenun Chirapapaisan; Pakornkit Phrueksaudomchai
Journal:  JMIR Mhealth Uhealth       Date:  2022-06-22       Impact factor: 4.947

3.  Glaucoma Medication and Quality of Life after Phacoemulsification Combined with a Xen Gel Stent.

Authors:  Christian Pahljina; Stephanie Sarny; Lukas Hoeflechner; Thomas Falb; Gernot Schliessleder; Marlene Lindner; Domagoj Ivastinovic; Kaweh Mansouri; Ewald Lindner
Journal:  J Clin Med       Date:  2022-06-15       Impact factor: 4.964

4.  Corneal Epithelial Cells Exhibit Myeloid Characteristics and Present Antigen via MHC Class II.

Authors:  Derek J Royer; Michael H Elliott; Yun Z Le; Daniel J J Carr
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-03-01       Impact factor: 4.799

5.  The correlation of cytokines and sensory hypersensitivity in mild dry eye patients characterized by symptoms outweighing signs.

Authors:  Bei Li; Ying Tian; Shuangyong Wang
Journal:  Mol Vis       Date:  2020-05-09       Impact factor: 2.367

Review 6.  Blood-Based Treatments for Severe Dry Eye Disease: The Need of a Consensus.

Authors:  Federico Bernabei; Matilde Roda; Marina Buzzi; Marco Pellegrini; Giuseppe Giannaccare; Piera Versura
Journal:  J Clin Med       Date:  2019-09-17       Impact factor: 4.241

Review 7.  Dry Eye Disease and Tear Cytokine Levels-A Meta-Analysis.

Authors:  Matilde Roda; Ivan Corazza; Maria Letizia Bacchi Reggiani; Marco Pellegrini; Leonardo Taroni; Giuseppe Giannaccare; Piera Versura
Journal:  Int J Mol Sci       Date:  2020-04-28       Impact factor: 5.923

8.  Evaluation of objective visual quality in dry eye disease and corneal nerve changes.

Authors:  Jiahui Ma; Shanshan Wei; Xiaodan Jiang; Yilin Chou; Yuexin Wang; Ran Hao; Jiarui Yang; Xuemin Li
Journal:  Int Ophthalmol       Date:  2020-07-02       Impact factor: 2.031

Review 9.  Modern approach to the treatment of dry eye, a complex multifactorial disease: a P.I.C.A.S.S.O. board review.

Authors:  Pasquale Aragona; Giuseppe Giannaccare; Rita Mencucci; Pierangela Rubino; Emilia Cantera; Maurizio Rolando
Journal:  Br J Ophthalmol       Date:  2020-07-23       Impact factor: 4.638

10.  Impact of Dry Eye Disease on Vision Quality: An Optical Quality Analysis System Study.

Authors:  Antoine Herbaut; Hong Liang; Ghislaine Rabut; Liem Trinh; Karima Kessal; Christophe Baudouin; Antoine Labbé
Journal:  Transl Vis Sci Technol       Date:  2018-07-12       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.